NeuroPace Inc.

NASDAQ: NPCE · Real-Time Price · USD
9.03
-0.29 (-3.11%)
At close: Aug 14, 2025, 3:59 PM
9.00
-0.33%
Pre-market: Aug 15, 2025, 05:33 AM EDT

NeuroPace Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
79.91M 65.42M 45.52M 45.18M
Cost of Revenue
20.82M 17.3M 13.03M 11.75M
Gross Profit
59.09M 48.12M 32.49M 33.44M
Operating Income
-21.67M -27.17M -40.79M -23.74M
Interest Income
3.02M 3.05M 1.58M 448K
Pretax Income
-27.14M -32.96M -47.08M -36.08M
Net Income
-27.14M -32.96M -47.08M -36.08M
Selling & General & Admin
57.1M 54.52M 51.34M 38.96M
Research & Development
23.65M 20.78M 21.95M 18.21M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
80.76M 75.3M 73.29M 57.17M
Interest Expense
8.8M 8.52M 7.53M 7.41M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
101.58M 92.59M 86.31M 68.92M
Income Tax Expense
n/a n/a 6.29M 2.03M
Shares Outstanding (Basic)
29.13M 25.85M 24.59M 24.45M
Shares Outstanding (Diluted)
29.13M 25.85M 24.59M 24.45M
EPS (Basic)
-0.93 -1.27 -1.91 -1.48
EPS (Diluted)
-0.93 -1.27 -1.91 -1.48
EBITDA
-16.57M -22.83M -36.57M -28.37M
EBIT
-18.34M -24.44M -39.55M -28.67M
Depreciation & Amortization
1.77M 1.6M 2.99M 296K